Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

So Far So Good: EU Member States On ‘Limited’ Experience With Clinical Trial Portal

Executive Summary

At a recent webinar on the EU Clinical Trial Information System (CTIS), representatives from different EU member states said the new system was working well and highlighted certain “good practices” for study sponsors to consider. 

You may also be interested in...



Centralized Templates To Help Harmonize Trial Dossiers Requirements Across The EU

Following feedback from its clinical trials expert group, the European Commission has published new and updated templates that sponsors can use to prepare study applications that would be acceptable in all the EU member states.

EU Sees Sharp Rise In Clinical Trial Applications Via New Portal

Notably more clinical trial applications were submitted to the new Clinical Trial Information System in July compared with previous months, according to new data that also shed light on how many submissions have been approved or rejected.

EU Rejects Calls To Extend Clinical Trial Regulation Transition Period

A senior European Commission official has a clear answer for those expecting the mandatory phase of the EU Clinical Trial Regulation to be delayed. There is no such plan on the cards.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS146746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel